Clinical Trials Logo
  1. Home
  2. Neuropathic Pain
  3. NCT01089855
  4. Details
NCT01089855 Clinical Trial

Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain

Neuropathic Pain Clinical Trial

Official title:
Phase IV Open Non Comparative Trial to Evaluate Efficacy and Safety of Tegretol® in Diabetes Neuropathy Pain.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01089855
Other study ID # CTEG111ZMA01
Secondary ID
Status Completed
Phase Phase 4
First received March 17, 2010
Last updated July 10, 2017
Start date December 2009

Study information
Verified date February 2011
Source Novartis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial is designed to evaluate the efficacy and tolerability of carbamazepine in neuropathic pain in diabetic patients

Recruitment information / eligibility
Status Completed
Enrollment 123
Est. completion date
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Diabetes patients with Diabetes neuropathy DN4 > or equal to 4

- Male or female aged from 21 to 65 years

- Informed consent

- HbA1C < 11%

Exclusion Criteria:

- Prior Hospitalization for Acido- cetosis

- Prior hospitalization for severe hypoglycemia

- Pregnancy

- Hepatitis

- Diabetes foot

- AVB (auriculo-ventricular conduction disturbance)

- Patient treated by antidepressant drugs

- Patient treated with other antiepileptic drug

- Patients with blood ion disturbance

- Patient with neutropenia

- Glaucoma

- Bladder Adenoma

- Alcohol abuse

- Creatinin clearance < 60 ml/ minute

Other protocol-defined inclusion/exclusion criteria may apply

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Carbamazepine

Locations
Country Name City State
Morocco Novartis Investigational Site Rabat

Sponsors (1)
Lead Sponsor Collaborator
Novartis

Country where clinical trial is conducted

Morocco, 

Outcome
Type Measure Description Time frame Safety issue
Primary The decrease of neuropathic pain in diabetic patients using Brief Pain Inventory scale (BPI) 12 weeks
Secondary Evaluate the tolerability of carbamazepine (including Adverse Events, Serious Adverse Events and abnormal laboratory finding) 12 weeks
Secondary Evaluate the quality of life 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04699734 - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Completed NCT05235191 - Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies Phase 3
Completed NCT05845177 - Persistent Pain After Hip Replacement
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Not yet recruiting NCT05949554 - Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
Withdrawn NCT05052645 - Ear Acupuncture for Neuropathic Pain N/A
Completed NCT02930551 - Neuromas as the Cause of Pain N/A
Completed NCT02824588 - Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain N/A
Completed NCT02866396 - Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement
Active, not recruiting NCT02560545 - Cannabinoids Effects on the Pain Modulation System N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Not yet recruiting NCT02246517 - The Effect of N2O on Chronic Neuropathic Pain Patients Phase 0
Completed NCT02099890 - The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury Phase 3
Completed NCT01946555 - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain N/A
Completed NCT01718821 - Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients N/A
Completed NCT01884662 - Virtual Walking for Neuropathic Pain in Spinal Cord Injury N/A
Completed NCT01669967 - The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin N/A
Completed NCT01201317 - A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy Phase 2
Completed NCT01207596 - Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain Phase 4

External Links